Ir.neogenomics.com is a subdomain of neogenomics.com, which was created on 2001-04-05,making it 23 years ago. It has several subdomains, such as lis.neogenomics.com , among others.
Description:NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them...
Discover ir.neogenomics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 117.596 KB |
Page Load Time: 0.737294 Seconds |
Website IP Address: 52.192.255.39 |
Apex Real Estate Brokerage Inc blog.apexrealestatebrokerage.com |
Home - ABI Document Support Services, Inc. - ABI Document Support Services, Inc. dev01.abidss.com |
NEO News Today | NEO & GAS powering the new Smart Economy dev.neonewstoday.com |
naomi neo naomi-neo.squarespace.com |
Center for NEO Studies neo.jpl.nasa.gov |
Credibase Inc. jobs |
Credibase Inc. openings |
Credibase Inc. careers credibase.recruiterbox.com |
Neo Vertika Condominium Home neovertikaw.vertilinc.com |
Home | Barcodes Inc CareersBarcodes Inc Careers | Barcodes Inc Careers careers.barcodesinc.com |
Collections – Landrys Inc - Landrys Inc Landrys Inc giftcards.landrysinc.com |
Moodle Web NEO moodle.polk-fl.net |
NEO LMS - The world's best LMS for Schools and Universities campus.bdginstitute.com |
Neo Group portal.neocelebrates.com |
Pokemon Neo Thunder | Online Pokemon RPG forum.pkmneothunder.com |
The Neo Geo Page neogeo.femvox.com |
M | Roof Hotel & Residences - Neo Modernist & Minimalist mroof.mboutiquehotels.com |
NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/ |
Company Information :: NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/company-information |
News & Events :: NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/news-events |
Financial Information - NeoGenomics, Inc. https://ir.neogenomics.com/financial-information |
SEC Filings - NeoGenomics, Inc. https://ir.neogenomics.com/sec-filings |
Corporate Governance - NeoGenomics, Inc. https://ir.neogenomics.com/corporate-governance |
Accessibility Statement :: NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/accessibility-statement |
NeoGenomics, Inc. (Nasdaq NEO) Tear Sheet https://ir.neogenomics.com/tear-sheet |
FAQ :: NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/company-information/faq |
Annual Reports :: NeoGenomics, Inc. (NEO) https://ir.neogenomics.com/sec-filings/annual-reports |
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million ... https://ir.neogenomics.com/news-events/press-releases/detail/200/neogenomics-reports-full-year-revenue-of-484-million-and |
NeoGenomics Reports First Quarter 2024 Results https://ir.neogenomics.com/news-events/press-releases/detail/266/neogenomics-reports-first-quarter-2024-results |
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results https://ir.neogenomics.com/news-events/press-releases/detail/233/neogenomics-reports-fourth-quarter-and-full-year-2022 |
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results https://ir.neogenomics.com/news-events/press-releases/detail/260/neogenomics-reports-fourth-quarter-and-full-year-2023 |
NeoGenomics Reports Revenue of $117 Million in the First Quarter https://ir.neogenomics.com/press-releases/detail/208/neogenomics-reports-revenue-of-117-million-in-the-first |
Date: Tue, 14 May 2024 19:49:41 GMT |
Server: Apache |
X-Frame-Options: SAMEORIGIN |
Strict-Transport-Security: max-age=31536000; |
X-XSS-Protection: 1; mode=block |
X-Content-Type-Options: nosniff |
Feature-Policy: "microphone none; camera none; geolocation none; screen-wake-lock none;", Referrer-Policy: strict-origin-when-cross-origin |
Content-Security-Policy: "default-src *.gstatic.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; script-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com *.googletagmanager.com googletagmanager.com browser-update.org *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.newrelic.com newrelic.com *.nr-data.net nr-data.net *.fontawesome.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline unsafe-eval; connect-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com *.googletagmanager.com googletagmanager.com browser-update.org *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.newrelic.com newrelic.com *.nr-data.net nr-data.net *.fontawesome.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline unsafe-eval; style-src fonts.googleapis.com *.gstatic.com *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com *.cloudflare.com cloudflare.com *.fontawesome.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; font-src cdnjs.cloudflare.com/ajax/libs/font-awesome/ fonts.googleapis.com *.gstatic.com *.fontawesome.com data: ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; img-src i.ytimg.com *.google-analytics.com google-analytics.com *.affec.tv affec.tv *.linkedin.com linkedin.com data: ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; frame-src *.google.com youtube.com www.youtube.com youtube-nocookie.com www.youtube-nocookie.com vimeo.com player.vimeo.com *.hcaptcha.com hcaptcha.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; object-src *.gstatic.com ir.stockpr.com ir.neogenomics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net;", Vary: Accept-Encoding |
Transfer-Encoding: chunked |
Content-Type: text/html; charset=UTF-8 |
content="ie=edge" http-equiv="x-ua-compatible"/ |
charset="utf-8"/ |
content="https://ir.neogenomics.com" property="og:url"/ |
content="NeoGenomics, Inc." property="og:site_name"/ |
content="Investor Relations" property="og:title"/ |
content="website" property="og:type"/ |
content="https://d1io3yog0oux5.cloudfront.net/_91c12578c98734c942f4520b1f7270bf/neogenomics/db/442/2093/social_image_resized.jpg" property="og:image"/ |
content="summary_large_image" name="twitter:card"/ |
content="NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's…" property="og:description"/ |
content="NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's…" name="description"/ |
content="initial-scale=1.0, width=device-width" name="viewport"/ |
content="#ffffff" name="theme-color"/ |
Ip Country: Japan |
City Name: Tokyo |
Latitude: 35.6893 |
Longitude: 139.6899 |
Diagnostic Services Methodologies Anatomic Pathology Cytogenetics FISH Flow Cytometry NGS Sponsored Testing Programs FOLR1 Ovarian Cancer Testing Program KRAS Single Gene Test Program Tech-Only Program Services Laboratory Collaboration Specialty Testing Neo Comprehensive - Heme Cancers Neo Comprehensive - Solid Tumor COMPASS® CancerTYPE ID® Hereditary Cancer InVisionFirst®-Lung Liquid Biopsy Liquid Biopsy NeoTYPE® Early-Stage NSCLC Panel Technology Solutions NeoAccess™ NeoSeek™ Pharma Services Why Choose NEO Expertise CDx Services Project Requirements and Compliance Lab Services Anatomic Pathology Molecular Multiplexed Immunofluorescence Flow Cytometry FISH & Cytogenetics CAR-T Services Informatics & Data Solutions Patients Billing In-home Blood Draws Testing Terminology Testing Methods and Tumor Profiling Sponsored Testing Programs for Patients Frequently Asked Questions InVisionFirst®-Lung (Liquid Biopsy) Test Menu Search Mobile Nav Investor Relations NeoGenomics Releases Inaugural ESG Report Press Release ESG Report Investor Relations Overview Investor Relations Investor Relations Overview News & Events Press Releases IR Calendar Presentations Literature Email Alerts Company Info Overview Executive Team Tear Sheet FAQ Financial Info Financial Results Income Statement Balance Sheet Cash Flow Stock Info Quote Charts Historical Data Analyst Coverage SEC Filings All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents ESG Report Company Overview NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company’s Pharma Services Division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad and San Diego, California; Research Triangle Park, North Carolina; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and Phoenix, Arizona; and CAP accredited laboratories in Cambridge, and United Kingdom. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States and Europe. View Executive Team View Board of Directors Latest News April 30, 2024 NeoGenomics Reports First Quarter 2024 Results View Press Release April 18, 2024 NeoGenomics Announces Senior Leadership Promotions View Press Release April 9, 2024 NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 View Press Release View All News Upcoming event May 23, 2024 10:00 am EDT 2024 Annual Meeting of Stockholders View Event Add to Calendar View All Events Latest presentation Apr 30, 2024 NeoGenomics Investor Presentation – April 2024 View Presentation View All Presentations Latest Financial Results Q1 2024 Quarter Ended Mar 31, 2024 Earnings Release HTML PDF Earnings Webcast Audio Presentation PDF 10-Q HTML PDF XBRL ZIP Latest Annual Filing For Fiscal Year Ending Dec 31, 2023 Report Links Annual Report Document Links View 10-K Email Alerts Sign up today and receive company updates straight to your inbox. Sign Up Today Stock Snapshot IR Contacts Headquarters NeoGenomics, Inc. 9490 NeoGenomics Way Fort Myers, FL 33912 T: 239-768-0600 F: 239-690-4237 Investor Relations Kendra Sweeney Investor Relations and ESG T: 239-877-7474 Kendra.sweeney@neogenomics.com Transfer Agent Broadridge Shareholder Services 1155 Long Island Avenue Edgewood, NY 11717-8309 T: (888) 789-8606 Accessibility statement Email alerts Company profile RSS news feed Footer navigation Diagnostic Services Pharma Services Informatics & Data Solutions Patients Test Menu Search Contact Us 9490 NeoGenomics Way Fort Myers, FL 33912 T: 239.768.0600 F: 239.690.4237 Glassdoor Linkedin Twitter YouTube More From Neo FOLR1 Ovarian Cancer Testing Program Lung Cancer Testing Biomarker Assist™ KRAS SGT Investigator-Initiated Trials (IIT) Request NeoNEWS Sign Up Receive weekly updates on NeoGenomics tests, research, events, and publications. First Name last Name Email Sign up for - None - Newsletter first name Leave this field blank One Lab. Vital Answers. Transforming Care for Cancer Patients. Search Footer Utility Client Services About Billing Contact Careers NeoLink Login Copyright © 2024 NeoGenomics Laboratories. All rights Reserved. Privacy . Privacy Settings . Terms . Licensing . Do not sell or share my personal information . Market Data copyright © 2024 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT =Real-Time, EOD =End of Day, PD =Previous Day. Market Data powered by QuoteMedia . Terms of Use . Search Main navigation Diagnostic Services Methodologies Anatomic Pathology Cytogenetics FISH Flow Cytometry NGS Sponsored Testing Programs FOLR1 Ovarian Cancer Testing Program KRAS Single Gene Test Program Tech-Only Program Services Laboratory Collaboration Specialty Testing Neo Comprehensive - Heme Cancers Neo Comprehensive - Solid Tumor COMPASS® CancerTYPE ID® Hereditary Cancer InVisionFirst®-Lung Liquid Biopsy Liquid Biopsy NeoTYPE® Early-Stage NSCLC Panel Technology Solutions NeoAccess™ NeoSeek™ Pharma Services Why Choose NEO Expertise CDx Services Project Requirements and Compliance Lab Services Anatomic Pathology Molecular Multiplexed Immunofluorescence Flow Cytometry FISH & Cytogenetics CAR-T Services Informatics & Data Solutions Patients Billing In-home Blood Draws Testing Terminology Testing Methods and Tumor Profiling Sponsored Testing Programs for Patients Frequently Asked Questions InVisionFirst®-Lung (Liquid Biopsy) Test Menu Search Header Utility Client Services Specimen Kits Online Orders Requisition Forms About Events Molecular Tumor Board Trade Shows Webinars Diagnostic Symposiums Newsroom Blog Press Releases Literature Podcast Videos Our Team Employee Benefits Investors NeoUniversity Corporate Stewardship Regulatory Good Faith Estimate Privacy Terms of Use Billing Patients Third Party Billing Careers Contact NeoLINK Login Phone number Glassdoor Icon Linkedin Icon Twitter Icon YouTube Icon...
Domain Name: NEOGENOMICS.COM Registry Domain ID: 68874051_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-05T09:41:51Z Creation Date: 2001-04-05T16:47:24Z Registry Expiry Date: 2031-04-05T16:47:24Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1353.AWSDNS-41.ORG Name Server: NS-2020.AWSDNS-60.CO.UK Name Server: NS-266.AWSDNS-33.COM Name Server: NS-954.AWSDNS-55.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:05:50Z <<<